Trump administration policies impact Canada-US relations and healthcare

The second Trump administration is significantly affecting Canada’s trade, military spending, and global relationships. Former Canadian Deputy Prime Minister Chrystia Freeland has warned that hostility toward dependable allies like Canada could undermine American power and economic stability, describing such actions as “superpower suicide.”

Economic tensions are rising as trade policies and tariffs threaten to increase costs for households and businesses in both nations. While Trump’s nationalism is marketed as strength, critics argue it imposes economic pain and squanders international trust, particularly regarding the USMCA framework.

Beyond trade, there are concerns regarding the impact on Canada’s healthcare system. The United States serves as the world’s largest pharmaceutical market, driving much of the global innovation in medicines. There is growing discussion regarding how the Trump administration’s Most Favoured Nation (MFN) drug pricing policy—which seeks to align U.S. prices with the lowest available in comparable developed countries—might affect pharmaceutical access and innovation in Canada.